Difference between revisions of "Combined Nuclear Medicine Biomarker Committee Call Summaries"
Jump to navigation
Jump to search
m |
m (→2016) |
||
| Line 1: | Line 1: | ||
==2016== | ==2016== | ||
| + | |||
| + | *[[Media:03 25 2016 QIBA Nuclear Medicine Leadership Call Summary-FINAL-AMS-esp.pdf|03.25.2016 QIBA Nuclear Medicine Leadership Call Summary]] | ||
*[[Media:02 26 2016 QIBA Nuclear Medicine Leadership Call Summary-DRAFT.pdf|02.26.2016 QIBA Nuclear Medicine Leadership Call Summary]] | *[[Media:02 26 2016 QIBA Nuclear Medicine Leadership Call Summary-DRAFT.pdf|02.26.2016 QIBA Nuclear Medicine Leadership Call Summary]] | ||
| − | |||
| − | |||
==2015== | ==2015== | ||